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A porcine model of severe combined immunodefi-
ciency (SCID) promises to facilitate human cancer
studies, the humanization of tissue for xenotrans-
plantation, and the evaluation of stem cells for clin-
ical therapy, but SCID pigs have not been described.
We report here the generation and preliminary evalu-
ation of a porcine SCID model. Fibroblasts contain-
ing a targeted disruption of the X-linked interleukin-
2 receptor gamma chain gene, Il2rg, were used as
donors to generate cloned pigs by serial nuclear
transfer. Germline transmission of the Il2rg deletion
produced healthy Il2rg+/ females, while Il2rg/Y
males were athymic and exhibited markedly
impaired immunoglobulin and T and NK cell produc-
tion, robustly recapitulating human SCID. Following
allogeneic bone marrow transplantation, donor cells
stably integrated in Il2rg/Y heterozygotes and re-
constituted the Il2rg/Y lymphoid lineage. The SCID
pigs described here represent a step toward the
comprehensive evaluation of preclinical cellular
regenerative strategies.The common gamma chain, IL2RG, is an IL-2 receptor subunit
(Takeshita et al., 1992) shared by IL-4, IL-7, IL-9, IL-15, and
IL-21 receptors (Kondo et al., 1993; Noguchi et al., 1993a;
Russell et al., 1993; Giri et al., 1994; Kimura et al., 1995;
Asao et al., 2001). IL2RG is present in T, NK, NKT, and dendritic
cells (Ishii et al., 1994) and plays an essential role in lymphoid
development by activating, through its cytoplasmic domain,
Janus kinase 3 (Nakamura et al., 1994; Nelson et al., 1994,
1997).
Mammalian IL2RG orthologs are typically located on the X
chromosome; in humans, IL2RG mutations result in X-linked
severe combined immunodeficiency (XSCID) in which T andNK cells are absent or profoundly reduced in number, while B
cells are numerically normal (or increased) but functionally
impaired (Noguchi et al., 1993b; Leonard, 1996; Fischer et al.,
1997). Gene-targeted mice lacking Il2rg also exhibit immunolog-
ical defects (Cao et al., 1995; Ohbo et al., 1996) including
the ablation of NK cell activity. NOD/SCID/Il2rgnull, NOG, and
Rag2null/Il2rgnull mice permit the functional reconstitution of
human hematopoietic and immune systems following the injec-
tion of purified human hematopoietic stem cells (Traggiai et al.,
2004; Ishikawa et al., 2005; Shultz et al., 2005). Unfortunately,
phenotypic differences exist between XSCID humans and Il2rg
null mice, including a pronounced numerical B cell reduction in
the latter. Two dog breeds develop SCID caused by Il2rg muta-
tions (Felsburg et al., 1999; Perryman, 2004), but dogs are poorly
characterized research models.
In contrast, the pig more closely resembles humans regarding
anatomy, hematology, physiology, size, and longevity. By
enabling long-term follow-up, pig models will permit the evalua-
tion of human cancer and stem cell transplantation over clinically
relevant time frames. We here describe disruption of the porcine
Il2rg gene to generate SCID pigs, their phenotypic characteriza-
tion, and proof-of-principle transplantation studies.
A conventional positive-negative selection Il2rg gene targeting
vector (TV) (Figure S1A) enabled the functional inactivation of
porcine Il2rg by removing exon 6 (Kanai et al., 1999). Following
fetal fibroblast transfection, selection, and PCR screening, 1 of
3 TV-targeted cell lines was expanded for nuclear transfer (Table
S1). Even after screening, PCR-positive colonies often contain
a substantial proportion of nontargeted cells (not shown) that
would result in a corresponding proportion of nontargeted
cloned pigs following nuclear transfer. To ensure that all clones
harbored a targeted Il2rg locus, we adopted a serial cloning
strategy. Nine embryonic day 35 (E35) or E39 nuclear transfer
embryos were collected and screened by PCR and Southern
blotting. PCR (not shown) and Southern blotting (Figure S1B) re-
vealed that six contained the genomic configuration predicted
for a single-targeted Il2rg allele. Fibroblasts were cultured from
one targeted embryo and used in secondary nuclear transfer toCell Stem Cell 10, 753–758, June 14, 2012 ª2012 Elsevier Inc. 753
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Il2rg-Targeted Nuclear Transfer SCID Pigsproduce 31 cloned F0 piglets; all were females heterozygously
targeted at their Il2rg genes as judged by PCR (not shown) and
Southern blotting (Figure S1C).
Fourteen of the 31 were stillborn and 3 of the 17 live-born died
neonatally of unknown cause(s) (Table S1). Ten survivors died
from pneumonia and severe arthritis (five were euthanized)
between postnatal day 7 (P7) and P70. The remaining four (#5,
9, 15 and 20) survived for >1 year.
Stillborn and neonatal fatalities often had spleens with hypo-
plastic lymphoid aggregations (Figure S1D). Most (24/31, 77%)
had undetectable or severely hypoplastic thymi (Figure S1E
and Table S2). F0 clones that died within 10 weeks also lacked
detectable thymi and had few, if any, T cells either in their
spleens or circulating (Figures S1F and S1G). In contrast, levels
of CD4+ and CD8+ T cells in four long-lived F0 lines were compa-
rable to those of WT controls. Analysis of peripheral blood (PB)
mononuclear cell (PBMC) RNA corroborated this: Il2rg, CD4,
and CD8 transcript levels were reduced in athymic Il2rg+/
clones that perished relative to respective levels in long-lived
clones and WT controls (Figure S1H).
Thus, most Il2rg+/ clones exhibited SCID-like phenotypes,
albeit that they had oneWT allele. We attributed this high propor-
tion to aberrant X-inactivation, a previously observed epigenetic
cloning phenotype (Senda et al., 2004; Nolen et al., 2005; Jiang
et al., 2008). However, epigenetic cloning phenotypes are cor-
rected by germline transmission (Shimozawa et al., 2002). To
confirm this and isolate the Il2rg+/ phenotype, we analyzed
progeny derived by fertilization from Il2rg+/ cloned female #9.
Female Il2rg+/ #9 inseminatedwithWT spermproduced 19 F1
(12 m, 7 f) offspring, and of these F1 offspring, two Il2rg
+/
females produced 21 F2 (13 m, 8 f) when inseminated with WT
sperm. Autopsies of representative F1 and F2 progeny revealed
that, as expected, all Il2rg/Y males had undetectable thymi,
whereas Il2rg+/ females had thymi of normal size (Figure 1A
and Table S3).
Hematological parameters in PB exhibited a significantly (p =
0.0041) reduced white blood cell (WBC) count in F1 Il2rg
/Y
males (6.4 ± 1.6 3 103/ml, n = 5) compared to WT controls
(17.8 ± 2.3 3 103/ml, n = 6), while hemoglobin levels and platelet
counts were unaffected (Figure 1B). F1 Il2rg
+/ females and WT
littermates yielded comparable PB T, NK, and B cell numbers,
indicative of intact acquired and innate immunity (Figures 1C,
1E, and 1F). In contrast, Il2rg/Y males harbored significantly
reduced PB T cells (Il2rg/Y males, 1.5% ± 1.0%; Il2rg+/Y males,
57.3% ± 4.3%; n = 4 each, p < 0.0001) and NK cells (Il2rg/Y
males, 0.1% ± 0.1%; Il2rg+/Y males, 3.6% ± 1.1%; n = 4 each,
p = 0.0162) (Figures 1D, 1E, and 1F). In proportion to the PB
reductions, Il2rg/Y spleens exhibited significant numericalFigure 1. Phenotypes of F1 and F2 Progeny Derived from Il2rg
+/– Clone
(A) Thymic phenotype in an Il2rg+/ female at 10 weeks and an Il2rg/Y male at 9
(B) Peripheral blood (PB) white blood cell (WBC), hemoglobin (Hgb), and platelet c
female littermates, and IL2rg/Y males.
(C) Identification of acquired and innate immune subsets in an Il2rg+/+ female by
T cells, and CD3CD16+ NK cells among the nonmyeloid fraction and myeloid c
(D) Analysis as for (C), but of an IL2rg/Y male.
(E) Proportion of CD3+ T cells in the spleen (spl), PB, and thymus (thy) in control
(F) Analysis as for (E), except showing the proportion of CD3CD16+ NK cells.
(G) Changes with time postpartum in serum IgG (left), IgA (middle), and IgM levereductions of T cells (Il2rg/Ymales, 2.3%± 1.1%; Il2rg+/Ymales,
13.0% ± 1.4%; n = 4 each, p = 0.0011) and NK cells (Il2rg/Y
males, 0.1% ± 0.0%; Il2rg+/Y males, 0.8% ± 0.2%; n = 4 each,
p = 0.0162) (Figures 1E and 1F). B cells and myeloid cells ac-
counted for the majority of CD45+ leukocytes in Il2rg/Y males,
indicating that their immune deficiency was limited to T and NK
cell lineages. The presence in Il2rg/Y males of CD33+ myeloid
cells with both mononuclear and polynuclear properties
suggests the differentiation of both granulocyte lineages and
antigen-presenting cells, including monocytes and dendritic
cells (Figures 1C and 1D).
We next evaluated humoral immune status in Il2rg-targeted
pigs (Figure 1G). Serum IgG and IgA levels were high at 1 week
(P7) and decreased gradually from 3 to 5 weeks in Il2rg/Y
(males), WT littermates, and Il2rg+/ female controls. After
7 weeks, IgG and IgA levels re-elevated in WT controls, while
levels of both remained low in Il2rg/Y males. Serum IgM was
low at 1 week and increased gradually in controls but remained
low in Il2rg/Ymales. Because both IgG and IgA at 1 week of age
are entirely transferred via the colostrum in pigs, these results
indicate that there had been no de novo Ig production in Il2rg/Y
males after weaning at 4 weeks. Impaired antibody production
by Il2rg/Y B cells is likely due to the absence of critical CD4+ T
helper cells. Consistent with their impaired immunity, all F1
Il2rg/Y males became systemically ill in the conventional
housing conditions used, while F1 Il2rg
+/ females appeared
healthy.
Collectively, this shows that when produced by conventional
breeding, Il2rg/Y F1 males, but not Il2rg
+/ females, present
SCID phenotypes. SCID-like phenotypes observed in many
Il2rg+/ female clones are attributable to aberrant, nonrandom
X-inactivation during somatic cell cloning. Following germline
transmission, Il2rg-targeted phenotypes resembled those of
X-linked SCID in other species, with greatly reduced T and NK
cell development and function (Cao et al., 1995; Puck et al.,
1987). Il2rg-targeted pigs harbor B cells and thereby recapitulate
human XSCID more closely than do Il2rg-targeted mice.
We next performed proof-of-principle allogeneic transplanta-
tion experiments using Il2rg-targeted pigs as recipients. Prelim-
inary conditioning with orally administered fludarabine and
busulfan produced significantly decreased WBC and platelet
counts (not shown), which might promote the engraftment of
transplanted cells. However, 2 of 6 Il2rg/Y males died within
2 weeks postadministration, suggesting that the regimen was
lethal for some piglets. Bone marrow (BM) cells fromWT siblings
were intravenously transplanted to four P11-12 Il2rg/Y males
with (#113, #115) or without (#605, #610) conditioning. Ubiqui-
tously GFP-expressing (#184) BM cells (Watanabe et al., 2005)#9 by Germline Transmission
weeks.
ount (Plt) at 2 months of age in WT controls, Il2rg+/+ female littermates, Il2rg+/
surface phenotype of CD45RA+CD3 B cells, CD3+CD4+ T cells, CD3+CD8+
ells.
Il2rg+/+ females and male Il2rg+/Y littermates and nonlittermates (WT).
ls. All error bars indicate SEM. See also Figure S1 and Tables S1–S3.
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Figure 2. Allogeneic Bone Marrow Transfer into Il2rg–/Y Males
(A–H) Flow cytometric quantification of each subtype of leukocytes in Il2rg/Y males (red lines) at different times after BM transfer. Controls are WT littermates
(blue lines) and Il2rg/Ymales (black lines) without BM transfer. (A)–(D) correspond to BMTwithout conditioning, the case for #605 and #610. (E)–(H) correspond to
BMT with conditioning, the case for #105, #113, and #122. (A) and (E) show the proportion of CD3+ T cells in PB at different times after BM transfer. (B) and (F)
show proportion of CD45RA+CD3 B cells in PB at different times after BM transfer. (C) and (G) show proportion of granulocytes in PB at different times after BM
transfer. (D) and (H) show proportion of monocytes in PB at different times after BM transfer.
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Recipient #115 died 15 days after BM transfer (BMT), possibly
due to conditioning toxicity, and recipient #605 died of presump-
tive pneumonia (not shown) 140 days posttransplantation;
nevertheless, it survived longer than Il2rg/Y controls without
BMT, which died within 54 days. The remaining three recipients
have survived >516 days (#610) and >321 days (#113 and #122)
posttransplantation, with PB T cell populations exhibiting similar
dynamics (Figures 2A and 2E); T cell counts increased6 weeks
posttransplantation and remained high. Following early vari-
ability, PB B cell counts equilibrated at detectably low levels.
The exception was #113, in which B cell counts were clearly
higher than those of WT controls until 16 weeks posttransplanta-
tion, gradually decreasing thereafter to a level comparable with
other recipients (Figures 2B and 2F). Compared to WT controls,
recipient #610 PB contained similar T cell counts and a dimin-
ished but substantial number of B and NK cells 42 weeks post-
transplantation (Figures 2A, 2B, and 2I). Similar profiles were
observed in #113 and 122 (Figures 2E and 2F; not shown for
NK). Surviving recipients and WT littermates had comparable
granulocyte and monocyte numbers (Figures 2C, 2D, 2G,
and 2H).
The provenance of immune cells in surviving recipients was
examined by microsatellite marker analysis of genomic DNA
from the ear, whole blood, and sorted T, B, and NK cells. GFP
fluorescence of immune cells was also detected in the case of
#122 (Figures 2E–2H and 2J). Lymphoid lineages were totally
of donor origin in all recipients. Myeloid lineages were mainly
of donor origin in #113 and of mixed donor/host origin in #122
and #610. Thus, our conditioning regimen enabled donor-
derived myeloid lineage reconstitution in #113, but not #122.
All surviving recipient PB contained IgG, IgA, and IgM (Figure 2K),
albeit at varying levels, strongly suggesting that humoral immu-
nity had been reconstituted and that donor-derived recipient
B cells produced antibodies. Thus, allogeneic BM transplanta-
tion to Il2rg/Y SCID pigs reproducibly resulted in enduring func-
tional donor cell engraftment and reconstituted acquired
immunity.
Assuming that the allogeneic model reported here reflects
the behavior of cells transplanted from different species,
SCID pigs promise to become a valuable tool in xenogeneic
transplantation studies of human stem cells, such as hemato-
poietic, embryonic, and induced pluripotent stem cells (Taka-
hashi et al., 2007). In particular, they promise to serve as
platforms for the evaluation of therapeutic outcomes over
several years, possibly after further genetic manipulation such
as disruption of recombination activating genes 1 or 2 (Rag1,
Rag2), which play critical roles in both cellular and humoral
immunity (Shinkai et al., 1992) and may facilitate efficient
human stem cell engraftment. Preliminary xenotransplantation
of human BM cells to porcine Il2rg/Y recipients in the absence
of preconditioning permitted limited engraftment, underscoring
the importance of further genetic manipulation, and optimized(I) Identification of immune subsets in recipient Il2rg/Ymale, #610, 12weeks postt
memory T cells, and CD3CD16+ NK cells among nonmyeloid and myeloid cells
(J) Representative microsatellite PCR analyses to distinguish between donor a
SWR1367 for # 113, and SW24 for #122).
(K) Changes of IgG (left), IgA (middle), and IgM levels in serum from recipients (repreconditioning (not shown). The porcine SCID model
described here therefore represents an essential step toward
the translational evaluation of human stem cells for long-term
clinical applications.SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure, three tables, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.stem.2012.04.021.
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